Sweden· SE-19670122000011
Celeston bifas 5,7 mg/ml Injektionsvätska, suspension
A medicinal product containing betamethasone acetate + betamethasone sodium phosphate, registered in Sweden by NV Organon.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Betamethasone Acetate + Betamethasone Sodium Phosphate
- Manufacturer
- NV Organon
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer19670122000011
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Betamethasone acetate + betamethasone sodium phosphate in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesBetaloan SUIKAsclemed USA, Inc.
- GermanyCelestan DepotOrganonhealthcare Gmbh
- NorwayCelestan DepotOrganon Healthcare GmbH
- FinlandCeleston ChronodoseN.V. Organon
- IcelandDiprospanN.V. Organon*
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Celestan Biphase, Diprophos
- Belgium · Celestone Chronodose, Diprophos Ampoule
- Bulgaria · Дипрофос
- Germany · Celestan Depot, Diprosone Depot 1 Ml Ampulle
- Denmark · Diprospan
- Spain · Celestone Cronodose
- Finland · Celeston Chronodose
- France · Celestene Chronodose, Diprostene
- Greece · Celestone Chronodose, Propiochrone
- Hungary · Diprophos
- Iceland · Diprospan
- Luxembourg · Celestone Chronodose, Diprophos Ampoule
- Netherlands · Celestone Chronodose
- Norway · Celeston Chronodose
- Poland · Diprophos
- Portugal · Diprofos Depot
- Romania · Diprophos
- Slovakia · Diprophos
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/79f34dfb-f93d-40b5-851d-20471474b12f GET /v1/drugs/79f34dfb-f93d-40b5-851d-20471474b12f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL",
"SmPC"
],
"se_npl_id": "19670122000011",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=19670122000011",
"product_doc_link": "https://docetp.mpa.se/LMF/Celeston%20bifas%20suspension%20for%20injection%20SmPC_09001bee807a1ff4.pdf"
}See everything about betamethasone acetate + betamethasone sodium phosphate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.